Who is this drug for? Bamlanivimab is a treatment option for people with 2 COVID-19 who: • Are age 12 or older What is COVID-19? • Weigh 88 pounds or more COVID-19 is a disease caused • Have had mild to moderate symptoms for 10 days by a type of virus called a or less coronavirus. Common symptoms • Are at high risk to get very sick from COVID-19 include fever, cough, and having trouble breathing. This drug is not for people who are already in the hospital because of their COVID-19 symptoms. Some people with COVID-19 have many symptoms, and some have Am I at high risk? few or no symptoms. And though For adults, bamlanivimab may be an option if you: most people get better within 2 weeks, some people are very sick • Are age 65 or older for a long time — or even die. • Have obesity, with a body mass index (BMI) of 35 or higher There’s no way to know for • Have diabetes, chronic kidney disease, or a sure who will get very sick with condition that weakens the immune system COVID-19, but some people are at higher risk, including older • Take medication that weakens the immune system adults and people with certain 4 • Are age 55 or older and have heart disease, high health conditions. blood pressure, or a long-term lung disease For pediatric patients age 12-17, bamlanivimab may be an option if you: 9 • Have obesity, with a BMI higher than 85 percent of patients your same age or gender • Have heart disease, sickle cell disease, or a long-term lung disease • Have a developmental condition like cerebral palsy • Regularly use medical technology, like a ventilator or feeding tube If you’re not sure whether bamlanivimab is right for you, talk with your doctor. For more detailed information about risk, see the Fact Sheet for Healthcare Providers at bamlanivimab.com. 2 U.S. Food and Drug Administration: http://pi.lilly.com/eua/bamlanivimab-eua-fda-authorization- letter.pdf 3 U.S. Centers for Disease Control and Prevention: https://www.cdc.gov/healthyweight/bmi/calculator.html 4 U.S. Centers for Disease Control and Prevention: cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms Page 2 | PP-BM-US-0009 November 2020 ©Lilly USA, LLC 2020. All rights reserved.

HCP-Patient Counseling Guide - Page 2 HCP-Patient Counseling Guide Page 1 Page 3